OC
LLY icon

Optimas Capital’s Eli Lilly LLY Stock Holding History

Optimas Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4,100
Closed -$3.2M – 38
2025
Q2 		$3.2M Buy
+4,100
New +$3.19M 3.37% 9
2024
Q3 		– Sell
-10,914
Closed -$8.25M – 29
2024
Q2 		$8.25M Sell
10,914
-2,008
-16% -$1.61M 9.38% 2
2024
Q1 		$10.1M Sell
12,922
-710
-5% -$505K 8.79% 2
2023
Q4 		$7.95M Sell
13,632
-2,254
-14% -$1.32M 7.5% 2
2023
Q3 		$8.53M Sell
15,886
-1,501
-9% -$773K 5.86% 6
2023
Q2 		$8.15M Buy
17,387
+7,281
+72% +$3.05M 9.42% 4
2023
Q1 		$3.47M Sell
10,106
-15,007
-60% -$5.06M 2.91% 14
2022
Q4 		$9.19M Buy
25,113
+2,403
+11% +$852K 9% 2
2022
Q3 		$7.34M Sell
22,710
-4,390
-16% -$1.39M 6.19% 5
2022
Q2 		$8.79M Buy
+27,100
New +$8.13M 10.78% 2

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Optimas Capital's LLY Position: Q3 2025 in Review

Optimas Capital sold out of Eli Lilly (LLY) in Q3 2025, closing a stake of 4,100 shares — an estimated $3.2M sold.

Optimas Capital first reported a position in LLY in Q2 2022 and held it in 10 quarters. The position peaked at $10.1M in Q1 2024. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • Optimas Capital reported no remaining Eli Lilly position as of Q3 2025 after selling out during the quarter.
  • Optimas Capital sold 4,100 Eli Lilly shares in Q3 2025, an estimated $3.2M.
  • Optimas Capital first reported a position in Eli Lilly in Q2 2022 and held it in 10 quarters.
  • Optimas Capital's Eli Lilly position peaked at $10.1M in Q1 2024.
  • 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on Optimas Capital's 13F filing for Q3 2025, filed 6 Nov 2025.